{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:31:40Z","timestamp":1781620300626,"version":"3.54.5"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoporosis and Sarcopenia"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.afos.2023.12.003","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T03:16:43Z","timestamp":1703042203000},"page":"115-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Musculoskeletal and neurocognitive clinical significance of adult hypophosphatasia"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0877-7562","authenticated-orcid":false,"given":"Se-Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9174-8369","authenticated-orcid":false,"given":"Funda","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1636-084X","authenticated-orcid":false,"given":"Steve","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8068-4577","authenticated-orcid":false,"given":"Vitaly","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8283-5076","authenticated-orcid":false,"given":"Tony","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5911-9522","authenticated-orcid":false,"given":"Mone","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.afos.2023.12.003_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"10.1016\/j.afos.2023.12.003_bib2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/archpedi.1948.02030020840003","article-title":"\u201cHYPOPHOSPHATASIA\u201d: a new developmental anomaly","volume":"75","author":"Rathbun","year":"1948","journal-title":"Am Dis Child"},{"key":"10.1016\/j.afos.2023.12.003_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.863940","article-title":"Characterization of genetic variants of uncertain significance for the ALPL gene in patients with adult hypophosphatasia","volume":"13","author":"Sanabria-de la Torre","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.afos.2023.12.003_bib4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.metabol.2017.08.013","article-title":"Hypophosphatasia","volume":"82","author":"Mornet","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.afos.2023.12.003_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/geno.1993.1305","article-title":"A homoallelic Gly317-->Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian mennonites","volume":"17","author":"Greenberg","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/j.afos.2023.12.003_bib6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1469-1809.2011.00642.x","article-title":"A molecular-based estimation of the prevalence of hypophosphatasia in the European population","volume":"75","author":"Mornet","year":"2011","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.afos.2023.12.003_bib7","doi-asserted-by":"crossref","first-page":"9569","DOI":"10.1038\/s41598-019-46004-2","article-title":"Epidemiological, clinical and genetic study of hypophosphatasia in a Spanish population: identification of two novel mutations in the Alpl Gene","volume":"9","author":"Garcia-Fontana","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.afos.2023.12.003_bib8","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1359\/jbmr.1999.14.12.2015","article-title":"Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia","volume":"14","author":"Fedde","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2023.12.003_bib9","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/ijms22031140","article-title":"Tissue nonspecific alkaline phosphatase function in bone and muscle progenitor cells: control of mitochondrial respiration and ATP Production","volume":"22","author":"Zhang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.afos.2023.12.003_bib10","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.3390\/cells10123338","article-title":"Tissue-nonspecific alkaline phosphatase, a possible mediator of cell maturation: towards a new paradigm","volume":"10","author":"Sato","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.afos.2023.12.003_bib11","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/humu.24010","article-title":"Large-scale in vitro functional testing and novel variant scoring via protein modeling provide insights into alkaline phosphatase activity in hypophosphatasia","volume":"41","author":"Del Angel","year":"2020","journal-title":"Hum Mutat"},{"key":"10.1016\/j.afos.2023.12.003_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bone.2013.01.024","article-title":"Clinical spectrum of hypophosphatasia diagnosed in adults","volume":"54","author":"Berkseth","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.afos.2023.12.003_bib13","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ejhg.2014.10","article-title":"Unexpected high intrafamilial phenotypic variability observed in hypophosphatasia","volume":"22","author":"Hofmann","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.afos.2023.12.003_bib14","first-page":"9","article-title":"Different dental manifestations in sisters with the same ALPL gne mutation: a report of two cases","author":"Kadota","year":"2022","journal-title":"Children"},{"key":"10.1016\/j.afos.2023.12.003_bib15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00198-013-2447-x","article-title":"Acute hypophosphatasemia","volume":"25","author":"McKiernan","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.12.003_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jbmr.3928","article-title":"Loss-of-function mutations in the ALPL gene presenting with adult onset osteoporosis and low serum concentrations of total alkaline phosphatase","volume":"35","author":"Alonso","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2023.12.003_bib17","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00774-023-01440-z","article-title":"Musculoskeletal pain and muscular weakness as the main symptoms of adult hypophosphatasia in a Spanish cohort: clinical characterization and identification of a new ALPL gene variant","volume":"41","author":"Calmarza","year":"2023","journal-title":"J Bone Miner Metabol"},{"key":"10.1016\/j.afos.2023.12.003_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13023-022-02393-8","article-title":"Clinical profiles of treated and untreated adults with hypophosphatasia in the Global HPP Registry","volume":"17","author":"Dahir","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.afos.2023.12.003_bib19","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00198-017-4087-z","article-title":"Clinical, radiographic and biochemical characteristics of adult hypophosphatasia","volume":"28","author":"Schmidt","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.12.003_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/ard.48.7.571","article-title":"Crystal deposition in hypophosphatasia: a reappraisal","volume":"48","author":"Chuck","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.afos.2023.12.003_bib21","first-page":"1244","article-title":"Recurrent calcific periarthritis, erosive osteoarthritis and hypophosphatasia: a family study","volume":"17","author":"Lassere","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.afos.2023.12.003_bib22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0002-9343(82)90474-0","article-title":"Adult hypophosphatasia with chondrocalcinosis and arthropathy. Variable penetrance of hypophosphatasemia in a large Oklahoma kindred","volume":"72","author":"Whyte","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.afos.2023.12.003_bib23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jbmr.2110","article-title":"Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters","volume":"29","author":"Gua\u00f1abens","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2023.12.003_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00198-020-05612-9","article-title":"Bone mineral density and fracture risk in adult patients with hypophosphatasia","volume":"32","author":"Genest","year":"2021","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.12.003_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12551","article-title":"Questioning the association between bisphosphonates and atypical femoral fractures","volume":"1335","author":"Pazianas","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.afos.2023.12.003_bib26","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1359\/jbmr.081253","article-title":"Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia","volume":"24","author":"Whyte","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2023.12.003_bib27","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s00198-018-4552-3","article-title":"Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all","volume":"29","author":"Genest","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.12.003_bib28","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00198-018-4571-0","article-title":"Abnormal bone turnover in individuals with low serum alkaline phosphatase","volume":"29","author":"L\u00f3pez-Delgado","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.12.003_bib29","doi-asserted-by":"crossref","first-page":"115795","DOI":"10.1016\/j.bone.2020.115795","article-title":"Clinical and biochemical characteristics of adults with hypophosphatasia attending a metabolic bone clinic","volume":"144","author":"Desborough","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.afos.2023.12.003_bib30","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1172\/JCI112031","article-title":"Markedly increased circulating pyridoxal-5'-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism","volume":"76","author":"Whyte","year":"1985","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.afos.2023.12.003_bib31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/jimd.12060","article-title":"Disorders affecting vitamin B(6) metabolism","volume":"42","author":"Wilson","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.afos.2023.12.003_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00198-018-4691-6","article-title":"Neurological symptoms in hypophosphatasia","volume":"30","author":"Colazo","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.12.003_bib33","doi-asserted-by":"crossref","first-page":"115695","DOI":"10.1016\/j.bone.2020.115695","article-title":"Characterization of physical, functional, and cognitive performance in 15 adults with hypophosphatasia","volume":"142","author":"Durrough","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.afos.2023.12.003_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ng0995-45","article-title":"Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6","volume":"11","author":"Waymire","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.afos.2023.12.003_bib35","doi-asserted-by":"crossref","first-page":"116204","DOI":"10.1016\/j.bone.2021.116204","article-title":"Hypophosphatasia: vitamin B(6) status of affected children and adults","volume":"154","author":"Whyte","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.afos.2023.12.003_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1570-9639(03)00045-1","article-title":"Pyridoxine-dependent seizures: a clinical and biochemical conundrum","volume":"1647","author":"Baxter","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.afos.2023.12.003_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11011-018-0322-3","article-title":"Alkaline phosphatase: a potential biomarker for stroke and implications for treatment","volume":"34","author":"Brichacek","year":"2019","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.afos.2023.12.003_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cne.20524","article-title":"Postnatal development of alkaline phosphatase activity correlates with the maturation of neurotransmission in the cerebral cortex","volume":"486","author":"Fonta","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.afos.2023.12.003_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00441-008-0681-x","article-title":"Distribution of ectonucleotidases in the rodent brain revisited","volume":"334","author":"Langer","year":"2008","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.afos.2023.12.003_bib40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/cercor\/bhh021","article-title":"Areal and subcellular localization of the ubiquitous alkaline phosphatase in the primate cerebral cortex: evidence for a role in neurotransmission","volume":"14","author":"Fonta","year":"2004","journal-title":"Cerebr Cortex"},{"key":"10.1016\/j.afos.2023.12.003_bib41","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.neuroscience.2010.10.049","article-title":"Layer-specific activity of tissue non-specific alkaline phosphatase in the human neocortex","volume":"172","author":"Negyessy","year":"2011","journal-title":"Neuroscience"},{"issue":"Pt. 2","key":"10.1016\/j.afos.2023.12.003_bib42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1469-7793.2001.00437.x","article-title":"Selective activation of nociceptors by P2X receptor agonists in normal and inflamed rat skin","volume":"534","author":"Hamilton","year":"2001","journal-title":"J Physiol"},{"key":"10.1016\/j.afos.2023.12.003_bib43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.bjp.0702258","article-title":"The effects of inflammation and inflammatory mediators on nociceptive behaviour induced by ATP analogues in the rat","volume":"126","author":"Hamilton","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.afos.2023.12.003_bib44","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1523\/JNEUROSCI.15-12-08031.1995","article-title":"Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal","volume":"15","author":"Aley","year":"1995","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.afos.2023.12.003_bib45","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.molmed.2010.12.006","article-title":"Pain-relieving prospects for adenosine receptors and ectonucleotidases","volume":"17","author":"Zylka","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.afos.2023.12.003_bib46","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1091\/mbc.e10-09-0740","article-title":"Tissue-nonspecific alkaline phosphatase promotes axonal growth of hippocampal neurons","volume":"22","author":"Diez-Zaera","year":"2011","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.afos.2023.12.003_bib47","doi-asserted-by":"crossref","first-page":"32539","DOI":"10.1074\/jbc.M110.145003","article-title":"Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tau","volume":"285","author":"D\u00edaz-Hern\u00e1ndez","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.afos.2023.12.003_bib48","first-page":"114","article-title":"Plasma alkaline phosphatase is elevated in Alzheimer's disease and inversely correlates with cognitive function","volume":"2","author":"Kellett","year":"2011","journal-title":"Int J Mol Epidemiol Genet"},{"key":"10.1016\/j.afos.2023.12.003_bib49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000329722","article-title":"Alkaline phosphatase is increased in both brain and plasma in Alzheimer's disease","volume":"9","author":"Vardy","year":"2012","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.afos.2023.12.003_bib50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ymgme.2006.02.012","article-title":"Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide","volume":"88","author":"Nishioka","year":"2006","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.afos.2023.12.003_bib51","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1359\/jbmr.071213","article-title":"Enzyme replacement therapy for murine hypophosphatasia","volume":"23","author":"Millan","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2023.12.003_bib52","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","article-title":"Enzyme-replacement therapy in life-threatening hypophosphatasia","volume":"366","author":"Whyte","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.afos.2023.12.003_bib53","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/jbm4.10052","article-title":"Fracture healing in two adult patients with hypophosphatasia after asfotase alfa therapy","volume":"2","author":"Klidaras","year":"2018","journal-title":"JBMR Plus"},{"key":"10.1016\/j.afos.2023.12.003_bib54","first-page":"e344","article-title":"Adult-onset hypophosphatasia: before and after treatment with asfotase alfa","volume":"5","author":"Magdaleno","year":"2019","journal-title":"AACE Clin Case Rep"},{"key":"10.1016\/j.afos.2023.12.003_bib55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bone.2019.05.036","article-title":"Recovery of bone mineralization and quality during asfotase alfa treatment in an adult patient with infantile-onset hypophosphatasia","volume":"127","author":"Rolvien","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.afos.2023.12.003_bib56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2018.12.011","article-title":"x-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia","volume":"121","author":"Kishnani","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.afos.2023.12.003_bib57","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/jbmr.1565","article-title":"\"Atypical femoral fractures\" during bisphosphonate exposure in adult hypophosphatasia","volume":"27","author":"Sutton","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2023.12.003_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10223","article-title":"Bisphosphonate use and fractures in adults with hypophosphatasia","volume":"3","author":"Rassie","year":"2019","journal-title":"JBMR Plus"},{"key":"10.1016\/j.afos.2023.12.003_bib59","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1210\/jc.2006-1902","article-title":"Adult hypophosphatasia treated with teriparatide","volume":"92","author":"Whyte","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2023.12.003_bib60","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.1210\/jc.2010-1168","article-title":"Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia","volume":"95","author":"Schalin-J\u00e4ntti","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2023.12.003_bib61","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4158\/EP15890.OR","article-title":"ADULT hypophosphatasia treated with teriparatide: report of 2 patients and review of the literature","volume":"22","author":"Camacho","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.afos.2023.12.003_bib62","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1172\/JCI83731","article-title":"Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia","volume":"127","author":"Seefried","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.afos.2023.12.003_bib63","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00774-017-0888-6","article-title":"Genetic analysis of adults heterozygous for ALPL mutations","volume":"36","author":"Taillandier","year":"2018","journal-title":"J Bone Miner Metabol"},{"key":"10.1016\/j.afos.2023.12.003_bib64","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ajmg.a.37991","article-title":"Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of hypophosphatasia","volume":"173","author":"Tenorio","year":"2017","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.afos.2023.12.003_bib65","first-page":"539","article-title":"[Infantile hypophosphatasia caused by a novel compound heterozygous mutation: a case report and pedigree analysis]","volume":"19","author":"Li","year":"2017","journal-title":"Zhong Guo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.afos.2023.12.003_bib66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","article-title":"Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients","volume":"75","author":"Whyte","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.afos.2023.12.003_bib67","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00774-011-0282-8","article-title":"Novel heterozygous tissue-nonspecific alkaline phosphatase (TNAP) gene mutations causing lethal perinatal hypophosphatasia","volume":"30","author":"Chang","year":"2012","journal-title":"J Bone Miner Metabol"},{"key":"10.1016\/j.afos.2023.12.003_bib68","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ymgme.2015.09.010","article-title":"Molecular diagnosis of hypophosphatasia and differential diagnosis by targeted Next Generation Sequencing","volume":"116","author":"Taillandier","year":"2015","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.afos.2023.12.003_bib69","doi-asserted-by":"crossref","first-page":"115664","DOI":"10.1016\/j.bone.2020.115664","article-title":"Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia","volume":"142","author":"Seefried","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.afos.2023.12.003_bib70","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171377","article-title":"Four novel mutations in the ALPL gene in Chinese patients with odonto, childhood, and adult hypophosphatasia","volume":"38","author":"Xu","year":"2018","journal-title":"Biosci Rep"}],"container-title":["Osteoporosis and Sarcopenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405525523001152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405525523001152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:35:27Z","timestamp":1762500927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405525523001152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2405525523001152"],"URL":"https:\/\/doi.org\/10.1016\/j.afos.2023.12.003","relation":{},"ISSN":["2405-5255"],"issn-type":[{"value":"2405-5255","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Musculoskeletal and neurocognitive clinical significance of adult hypophosphatasia","name":"articletitle","label":"Article Title"},{"value":"Osteoporosis and Sarcopenia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.afos.2023.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Korean Society of Osteoporosis. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}